Register to view:
Efficient multiplexed targeted gene editing as a strategy to generate improved CHO host cell lines for biotherapeutic manufacturing applications.
Read our new whitepaper in collaboration with Cergentis, where we showcase Horizon’s newly developed multiplexed gene editing strategy, and how it can be applied to engineering improved expressing cell lines for biotherapeutic manufacturing applications.
Have an account? •